Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic.

"Disclosure J.E.E. has served on clinical advisory boards for Paion, has served on the clinical advisory board for and has share options in Satisfai Health, and reports speaker fees from Falk, Janssen, and Medtronic. K.J.M. and J.E.E. were contributors to the BSG working group for FIT guidelines in symptomatic patients. The authors declare no other conflict of interest."

"Funding This emergency clinical service was supported by funding from the 40tude Curing Colon Cancer Charity. Additional support was provided by Mast Group Ltd, through their generous donation of FIT kits (OC-SENSOR™, Eiken Chemical Co., Ltd, Tokyo, Japan). J.E.E. is funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. A.G.L. is supported by a King’s College London Centre for Doctoral Studies Postgraduate Research (PGR) International Scholarship and S.R.S. is supported by Peter Sasieni grant, Cancer Research UK (grant number C8162/A16892); neither funder had a role in the preparation of the manuscript or the decision to submit for publication."